公开(公告)号：US20170258377A1

公开(公告)日：2017-09-14

申请号：US15607099

申请日：2017-05-26

Applicant: Abbott Diabetes Care Inc.

Inventor： Udo Hoss ,  Benjamin J. Feldman ,  Tianmei Ouyang

IPC: A61B5/1468 ,  C12Q1/00 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1486

CPC classification number: A61B5/1468 ,  A61B5/14507 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/1486 ,  A61B5/14865 ,  A61B5/4839 ,  C12Q1/002

Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a membrane structure with an analyte permeability that is substantially temperature independent. The devices also include a sensing layer disposed on a working electrode of in vivo analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.

公开(公告)号：US09492112B2

公开(公告)日：2016-11-15

申请号：US14806424

申请日：2015-07-22

Applicant: Abbott Diabetes Care Inc.

Inventor： Balasubrahmanya S. Bommakanti ,  Gary Sandhu ,  Udo Hoss ,  Geoffrey V. McGarraugh

IPC: G01N27/327 ,  A61B5/1486 ,  C12Q1/00 ,  A61B5/145 ,  A61B5/1473 ,  A61B5/1495 ,  A61B5/00 ,  A61K38/28

CPC classification number: A61B5/14865 ,  A61B5/14532 ,  A61B5/1473 ,  A61B5/1495 ,  A61B5/4839 ,  A61B5/6847 ,  A61B5/742 ,  A61B5/746 ,  A61K38/28 ,  C12Q1/004 ,  C12Q1/006 ,  G01N27/3271 ,  G01N27/3272

Abstract: Generally, embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have improved uniformity of distribution of the sensing layer by inclusion of a high-boiling point solvent, where the sensing layer is disposed proximate to a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.

公开(公告)号：US20130150691A1

公开(公告)日：2013-06-13

申请号：US13710460

申请日：2012-12-11

Applicant: Abbott Diabetes Care Inc.

Inventor： Louis Pace ,  Peter G. Robinson ,  Udo Hoss ,  Samuel Mason Curry ,  Phillip William Carter ,  Vincent Michael DiPalma ,  Amit Mhatre ,  Jennifer Olson ,  Manuel Luis Miguel Donnay ,  Marc Barry Taub

IPC: A61B5/145

CPC classification number: A61B5/14503 ,  A61B5/0004 ,  A61B5/1411 ,  A61B5/1451 ,  A61B5/14532 ,  A61B5/150022 ,  A61B5/150305 ,  A61B5/150335 ,  A61B5/150358 ,  A61B5/150389 ,  A61B5/150503 ,  A61B5/150748 ,  A61B5/15087 ,  A61B5/150877 ,  A61B5/15105 ,  A61B5/15144 ,  A61B5/157 ,  A61B5/6849 ,  A61B50/3001 ,  A61B2560/0443 ,  A61B2560/063 ,  A61B2562/242

Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.

Abstract translation: 公开了与体内分析物传感器单元相关联的装置。 这些装置包括体内传感器单元本身的任何包装和/或加载系统，施用器和元件。 此外，公开了将电化学分析物传感器连接到和/或在相关的体内分析物传感器单元内的各种方法。 连接器的方法各不相同地涉及使用独特的传感器和辅助元件布置，以便于组装分离的电子组件和传感器元件，这些组件和传感器元件保持分离直到最终用户将它们放在一起。

公开(公告)号：US12279867B2

公开(公告)日：2025-04-22

申请号：US18233935

申请日：2023-08-15

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Steven Scott ,  Christopher J. Bennell ,  Claire Bhogal ,  Katie A. Cranfield ,  Marc B. Taub ,  Bree M. Winter ,  Owen D. Reynolds ,  Jean-Pierre Babka ,  Dharmendra S. Patel ,  Christopher A. Thomas ,  Udo Hoss ,  Mark S. Yahnke ,  Tahir S. Khan

IPC: A61B5/1495 ,  A61B5/00 ,  A61B5/145 ,  A61M1/16

Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.

公开(公告)号：US20240324917A1

公开(公告)日：2024-10-03

申请号：US18621456

申请日：2024-03-29

Applicant: Abbott Diabetes Care, Inc.

Inventor： Albert Gutes ,  Kevin P. Wallis ,  John V. Latour ,  Balasubrahmanya S. Bommakanti ,  Udo Hoss ,  Mark S. Yahnke ,  Tahir Khan ,  Tianmei Ouyang ,  Jacob W. Clary

IPC: A61B5/1486 ,  C08F226/06

CPC classification number: A61B5/14865 ,  C08F226/06

Abstract: The present invention provides systems, devices and methods for in vivo monitoring of an analyte level. In particular, the present invention relates to improved sensors for use in in vivo monitoring of an analyte level.

公开(公告)号：US20240090801A1

公开(公告)日：2024-03-21

申请号：US18374887

申请日：2023-09-29

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Mohammad E. Moein ,  Louis G. Pace ,  Udo Hoss ,  Phu X. Le ,  Samuel Mason Curry

IPC: A61B5/1486 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1468 ,  A61B5/1473 ,  H05K3/32

CPC classification number: A61B5/1486 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/1468 ,  A61B5/1473 ,  A61B5/4839 ,  A61B5/6848 ,  H05K3/325 ,  A61B2562/227 ,  H01L24/72 ,  H01L2924/07811 ,  H01L2924/12042 ,  H05K2201/10401 ,  Y10T29/4913

Abstract: Glucose monitoring devices and related systems and methods, the glucose monitoring devices including a sensor electronics unit having a housing and a printed circuit board disposed within the housing, a transcutaneous glucose sensor assembly, and a conductive sensor connector. The printed circuit board includes a first electrical contact, the transcutaneous glucose sensor assembly includes a distal portion having a working electrode and proximal portion having a working-electrode contact in electrical communication with the working electrode, and the conductive sensor connector electrically connects the working-electrode contact with the first electrical contact. Further, the conductive sensor connector extends through a hole in the proximal portion of the transcutaneous glucose sensor assembly and through a hole in the printed circuit board.

公开(公告)号：US11867652B2

公开(公告)日：2024-01-09

申请号：US17682653

申请日：2022-02-28

Applicant: Abbott Diabetes Care Inc.

Inventor： Udo Hoss ,  Tahir Sadik Khan ,  Phu X. Le

IPC: G01N27/327 ,  H01M4/02 ,  A61B5/1486 ,  G01N27/413

CPC classification number: G01N27/3271 ,  A61B5/1486 ,  G01N27/413 ,  H01M4/02

Abstract: An analyte sensor comprising: a non-conductive material; a conductive material disposed on the non-conductive material; and at least two sensing structures defined by a removed portion of the conductive material, the at least two sensing structures comprising a reagent composition.

公开(公告)号：US20230397849A1

公开(公告)日：2023-12-14

申请号：US18454593

申请日：2023-08-23

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Udo Hoss ,  John Charles Mazza ,  Phu Le

IPC: A61B5/145 ,  A61B5/1486 ,  A61B5/00

CPC classification number: A61B5/14532 ,  A61B5/14865 ,  A61B5/6833 ,  A61B5/7221 ,  A61B2562/227 ,  A61B5/002 ,  A61B2560/0443

Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.

公开(公告)号：US20230389838A1

公开(公告)日：2023-12-07

申请号：US18233935

申请日：2023-08-15

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Steven Scott ,  Christopher J. Bennell ,  Claire Bhogal ,  Katie A. Cranfield ,  Marc B. Taub ,  Bree M. Winter ,  Owen D. Reynolds ,  Jean-Pierre Babka ,  Dharmendra S. Patel ,  Christopher A. Thomas ,  Udo Hoss ,  Mark S. Yahnke ,  Tahir S. Khan

IPC: A61B5/1495 ,  A61B5/145

CPC classification number: A61B5/1495 ,  A61B5/14503 ,  A61B5/14532 ,  A61B5/14546 ,  A61M1/1603

Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.

公开(公告)号：US20220359074A1

公开(公告)日：2022-11-10

申请号：US17864931

申请日：2022-07-14

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Daniel Milfred Bernstein ,  Martin J. Fennell ,  Mark Kent Sloan ,  Michael Love ,  Lei He ,  Christopher Allen Thomas ,  Udo Hoss ,  Benjamin Jay Feldman ,  Kenneth J. Doniger ,  Gary Ashley Stafford ,  Gary Alan Hayter ,  Phillip Yee ,  Namvar Kiaie ,  Jean-Pierre Cole ,  Marc Barry Taub ,  Louis George Pace ,  Jeffery Mario Sicurello

IPC: G16H40/67 ,  G01N33/487 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1486 ,  A61B5/01 ,  G16H40/63

Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.